AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 648737 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone A 25 mg four times daily)
Number of subjects: 0
Study 648737 — intervention group
Group type: COMPARATOR
Intervention: Frusemide alone
Number of subjects: 0
Study 648737 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide plus Aldactone-A
Number of subjects: 0
Study 648737 — intervention group
Group type: COMPARATOR
Intervention: Frusemide plus Slow-K
Number of subjects: 0
Study 31293259 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding (initiated at 8 hours post-operation)
Number of subjects: 282
Study 31293259 — intervention group
Group type: COMPARATOR
Intervention: Delayed oral feeding (initiated at 48 hours post-operation)
Number of subjects: 282
Study 31293259 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding
Number of subjects: 282
Study 31293259 — intervention group
Group type: COMPARATOR
Intervention: Delayed oral feeding
Number of subjects: 282
Study 28692544 — intervention group
Group type: EXPERIMENTAL
Intervention: High school attendance (≥80% school days)
Number of subjects: 0
Study 28692544 — intervention group
Group type: EXPERIMENTAL
Intervention: School dropout
Number of subjects: 0
Study 26466908 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management support with pain science education and exercise (6-week program)
Number of subjects: 110
Study 26466908 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 110
Study 23416857 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine (20 mg, oral) in paired conditions with contextual cues
Number of subjects: 0
Study 23416857 — intervention group
Group type: COMPARATOR
Intervention: Placebo in paired conditions with contextual cues
Number of subjects: 0
Study 23416857 — intervention group
Group type: COMPARATOR
Intervention: Methamphetamine (20 mg, oral) in unpaired conditions
Number of subjects: 0
Study 23416857 — intervention group
Group type: COMPARATOR
Intervention: Placebo in unpaired conditions
Number of subjects: 0
Study 23416857 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired group without monetary incentives
Number of subjects: 0
Study 21203888 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise at 65% of peak VO2 for 1 hour during MF and ML phases
Number of subjects: 10
Study 21203888 — intervention group
Group type: COMPARATOR
Intervention: Baseline evaluation
Number of subjects: 10
Study 19671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol Contramid OAD 100 mg
Number of subjects: 685
Study 19671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol Contramid OAD 200 mg
Number of subjects: 685
Study 19671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol Contramid OAD 300 mg
Number of subjects: 685
Study 19671089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 685
Study 17460496 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk (CM)
Number of subjects: 65
Study 17460496 — intervention group
Group type: COMPARATOR
Intervention: Infant formula (IF)
Number of subjects: 65
Study 17460496 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk (CM) with fish oil (FO) supplement
Number of subjects: 65
Study 17460496 — intervention group
Group type: COMPARATOR
Intervention: Infant formula (IF) with fish oil (FO) supplement
Number of subjects: 65
Study 14983576 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium supplementation (1000 micrograms)
Number of subjects: 0
Study 14983576 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 11783823 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical nerve stimulation
Number of subjects: 0
Study 11783823 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 0
Study 11783823 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture, transcutaneous electrical nerve stimulation, acupuncture‐like transcutaneous nerve stimulation, laser therapy, neuroreflexotherapy
Number of subjects: 0
Study 9493258 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A treatment (one capsule)
Number of subjects: 0
Study 9493258 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A treatment (two doses)
Number of subjects: 0
Study 9493258 — intervention group
Group type: COMPARATOR
Intervention: Vitamin A treatment (no pills taken)
Number of subjects: 0
Study 7831628 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhalation TLCO (TLCO,ex)
Number of subjects: 100
Study 7831628 — intervention group
Group type: COMPARATOR
Intervention: Standard 10 second breath holding TLCO (TLCO,bh)
Number of subjects: 100
Study 3071767 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and phosphorus supplementation
Number of subjects: 26
Study 3071767 — intervention group
Group type: COMPARATOR
Intervention: Control group (42 very low birth weight infants (VLBWI) and 83 LBWI appropriate for gestational age (AGA))
Number of subjects: 26
Study 28952798 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower BP target (SBP < 130 mm Hg)
Number of subjects: 1331
Study 26303892 — intervention group
Group type: EXPERIMENTAL
Intervention: On-off design intervention
Number of subjects: 2
Study 26303892 — intervention group
Group type: COMPARATOR
Intervention: Control group (off)
Number of subjects: 2
Study 23161893 — intervention group
Group type: EXPERIMENTAL
Intervention: Community education program utilizing street dramas, poster campaigns, leaflets, and individual and group discussions.
Number of subjects: 0
Study 23161893 — intervention group
Group type: COMPARATOR
Intervention: Control village with no intervention.
Number of subjects: 0
Study 21534184 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice for 'virtual movement' of the radiocarpal joint
Number of subjects: 21
Study 21534184 — intervention group
Group type: COMPARATOR
Intervention: Not treated at all (Control)
Number of subjects: 21
Study 18719064 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid (LZD), 600 mg
Number of subjects: 149
Study 18719064 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (VAN), 1 g every 12 h
Number of subjects: 149
Study 18719064 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid (LZD)
Number of subjects: 149
Study 18719064 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (VAN)
Number of subjects: 149
Study 16423119 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted physician-directed intervention
Number of subjects: 235
Study 16423119 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 235
Study 12940564 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraLume 2 LED light for 20 seconds
Number of subjects: 40
Study 12940564 — intervention group
Group type: COMPARATOR
Intervention: Ortholux halogen curing light for 20 seconds
Number of subjects: 40
Study 10704632 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (initial dose 10 mg, max 80 mg)
Number of subjects: 1028
Study 10704632 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (initial dose 10 mg, max 40 mg, supplemented with 4 g cholestyramine if necessary)
Number of subjects: 1028
Study 10704632 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg)
Number of subjects: 1028
Study 10704632 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (10 mg)
Number of subjects: 1028
Study 10704632 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (for baseline cholesterol 5.6-6.5 mmol/l)
Number of subjects: 1028
Study 10704632 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (for baseline cholesterol 5.6-6.5 mmol/l)
Number of subjects: 1028
Study 10704632 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (for baseline cholesterol 7.6-8.5 mmol/l)
Number of subjects: 1028
Study 10704632 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (for baseline cholesterol 7.6-8.5 mmol/l)
Number of subjects: 1028
Study 9346224 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (175 mg/m2) with carboplatin (AUC 7)
Number of subjects: 90
Study 9346224 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel (175 mg/m2) with carboplatin (AUC 7) alternating with cisplatin (75 mg/m2)
Number of subjects: 90
Study 7971879 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help manual smoking cessation intervention
Number of subjects: 265
Study 7971879 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 265
Study 2637911 — intervention group
Group type: EXPERIMENTAL
Intervention: PT-01 (controlled-release insert containing ofloxacin)
Number of subjects: 46
Study 2637911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 2637911 — intervention group
Group type: EXPERIMENTAL
Intervention: PT-01
Number of subjects: 46
Study 974477 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical transposition of the ovaries
Number of subjects: 10
Study 974477 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ovaria transposition)
Number of subjects: 10
Study 31300065 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Cutting Down Programme (CDP)
Number of subjects: 700
Study 31300065 — intervention group
Group type: COMPARATOR
Intervention: Online Psychoeducation
Number of subjects: 700
Study 28061037 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic surgery (SPLS)
Number of subjects: 62
Study 28061037 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery (CLS)
Number of subjects: 62
Study 25423960 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 adjuvant chemotherapy (S-1(+)-group) administered after 2003
Number of subjects: 38
Study 25423960 — intervention group
Group type: COMPARATOR
Intervention: No S-1 adjuvant chemotherapy (S-1(-)-group) before 2003
Number of subjects: 38
Study 23530078 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination artesunate (AS)/amodiaquine (AQ) therapy
Number of subjects: 109
Study 21791541 — intervention group
Group type: EXPERIMENTAL
Intervention: Low homoarginine levels
Number of subjects: 1255
Study 21791541 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest homoarginine quintile
Number of subjects: 1255
Study 18751881 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimuli of different salience presented to participants with ASD
Number of subjects: 0
Study 18751881 — intervention group
Group type: COMPARATOR
Intervention: Matched control participants
Number of subjects: 0
Study 18751881 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-selected color extinguished in Experiment 3
Number of subjects: 0
Study 16458644 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulprostone
Number of subjects: 103
Study 16458644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 15499517 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposome eye spray (TEARS AGAIN, Optima Pharmaceutical GmbH, Germany)
Number of subjects: 382
Study 15499517 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (control)
Number of subjects: 382
Study 15499517 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposome eye spray (TEARS AGAIN)
Number of subjects: 382
Study 11755562 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol therapy for high cardiac output (greater than 7.4 L/minute)
Number of subjects: 46
Study 11755562 — intervention group
Group type: COMPARATOR
Intervention: Control group (low risk, not treated)
Number of subjects: 46
Study 8950737 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (E)
Number of subjects: 57
Study 8950737 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 57
Study 1720486 — intervention group
Group type: EXPERIMENTAL
Intervention: isradipine 1.25-2.5 mg twice daily
Number of subjects: 12
Study 1720486 — intervention group
Group type: COMPARATOR
Intervention: metoprolol 50-100 mg twice daily
Number of subjects: 12
Study 6817845 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate treatment for 6 months
Number of subjects: 179
Study 6817845 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C treatment for 6 months
Number of subjects: 179
Study 29962032 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF with EPO (Group A; n = 30)
Number of subjects: 60
Study 29962032 — intervention group
Group type: COMPARATOR
Intervention: G‐CSF and placebo (Group B; n = 30)
Number of subjects: 60
Study 28414610 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for 90-day mortality
Number of subjects: 22654
Study 28414610 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable model for 90-day mortality
Number of subjects: 22654
Study 26380359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Therapy (CBGT), 12 sessions
Number of subjects: 81
Study 26380359 — intervention group
Group type: COMPARATOR
Intervention: Usual outpatient psychiatric care
Number of subjects: 81
Study 23585303 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of biapenem 0.15 g
Number of subjects: 10
Study 23585303 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of biapenem 0.3 g
Number of subjects: 10
Study 23585303 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of biapenem 0.6 g
Number of subjects: 10
Study 23585303 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of biapenem 0.3 g
Number of subjects: 10
Study 23585303 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 10
Study 20615931 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g/kg glycine
Number of subjects: 12
Study 20615931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 19820270 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 50 mg with omeprazole (40 mg/day for 14 days)
Number of subjects: 24
Study 19820270 — intervention group
Group type: COMPARATOR
Intervention: Lisdexamfetamine dimesylate (LDX) 50 mg without omeprazole
Number of subjects: 24
Study 19820270 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed amphetamine salts extended-release (MAS XR) 20 mg with omeprazole (40 mg/day for 14 days)
Number of subjects: 24
Study 19820270 — intervention group
Group type: COMPARATOR
Intervention: Mixed amphetamine salts extended-release (MAS XR) 20 mg without omeprazole
Number of subjects: 24
Study 19820270 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS XR with omeprazole
Number of subjects: 24
Study 19820270 — intervention group
Group type: EXPERIMENTAL
Intervention: LDX with omeprazole
Number of subjects: 24
Study 17542205 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin aged in mineral oil
Number of subjects: 0
Study 17542205 — intervention group
Group type: COMPARATOR
Intervention: Dentin aged in artificial saliva
Number of subjects: 0
Study 14690849 — intervention group
Group type: EXPERIMENTAL
Intervention: One temporal standard encoded
Number of subjects: 0
Study 14690849 — intervention group
Group type: EXPERIMENTAL
Intervention: Two temporal standards encoded
Number of subjects: 0
Study 11231932 — intervention group
Group type: EXPERIMENTAL
Intervention: Racecadotril (1.5 mg/kg orally 3 times daily)
Number of subjects: 172
Study 11231932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 9888613 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan (5, 10, 15, or 20 mg)
Number of subjects: 13
Study 9888613 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam (2 mg)
Number of subjects: 13
Study 10350383 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 250 mg od
Number of subjects: 832
Study 10350383 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg od
Number of subjects: 832
Study 10350383 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime axetil 250 mg bd
Number of subjects: 832
Study 2620999 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal bogus‐pipeline protocol (VBP)
Number of subjects: 152
Study 2620999 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed cartoon bogus‐pipeline (CBP)
Number of subjects: 152
Study 2620999 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire‐only control (QOC)
Number of subjects: 152
Study 835924 — intervention group
Group type: COMPARATOR
Intervention: Guar gum
Number of subjects: 12
Study 835924 — intervention group
Group type: COMPARATOR
Intervention: Pectin (10 g added to marmalade)
Number of subjects: 12
Study 835924 — intervention group
Group type: COMPARATOR
Intervention: Guar and pectin combined
Number of subjects: 12
Study 31895459 — intervention group
Group type: EXPERIMENTAL
Intervention: New cardiovascular drugs (lipid-modifying, antithrombotic, anti-inflammatory, and antidiabetic drugs)
Number of subjects: 8569
Study 31895459 — intervention group
Group type: EXPERIMENTAL
Intervention: New cardiovascular drugs
Number of subjects: 8569
Study 28368956 — intervention group
Group type: EXPERIMENTAL
Intervention: Low volume plyometric group (LPG)
Number of subjects: 36
Study 28368956 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume plyometric group (HPG)
Number of subjects: 36
Study 28368956 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study 28368956 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg stiffness
Number of subjects: 36
Study 29141082 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructions on how best to take photographs using a smartphone (intervention group)
Number of subjects: 40
Study 29141082 — intervention group
Group type: COMPARATOR
Intervention: No instructions on how to take photographs (control group)
Number of subjects: 40
Study 29141082 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall photograph-based diagnosis
Number of subjects: 40
Study 29141082 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality photographs subgroup
Number of subjects: 40
Study 25773480 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral morphine at doses of 0.1 mg/kg, 0.2 mg/kg, and 0.3 mg/kg
Number of subjects: 40
Study 24245597 — intervention group
Group type: EXPERIMENTAL
Intervention: Two group-based sessions focused on HIV risk and prevention knowledge and condom skills
Number of subjects: 200
Study 24245597 — intervention group
Group type: COMPARATOR
Intervention: Single-session HIV review
Number of subjects: 200
Study 21118280 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 60 mg
Number of subjects: 591
Study 21118280 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 90 mg
Number of subjects: 591
Study 21118280 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 60 mg and 90 mg
Number of subjects: 591
Study 18810712 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral DHEA (9 subjects)
Number of subjects: 15
Study 18810712 — intervention group
Group type: COMPARATOR
Intervention: Placebo (6 subjects)
Number of subjects: 15
Study 17302022 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy extracorporeal shock wave treatment (ESWT)
Number of subjects: 0
Study 17302022 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 0
Study 15577002 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protectors
Number of subjects: 0
Study 11208687 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour sodium deprivation (decreasing Na)
Number of subjects: 47
Study 9237964 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g/d olestra
Number of subjects: 67
Study 9237964 — intervention group
Group type: COMPARATOR
Intervention: 10 g/d triglyceride
Number of subjects: 67
Study 9237964 — intervention group
Group type: EXPERIMENTAL
Intervention: 0, 8, 20 or 32 g olestra in potato chips
Number of subjects: 67
Study 8257487 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (100 mg daily)
Number of subjects: 36
Study 8257487 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin (500 mg daily)
Number of subjects: 36
Study 8257487 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin (500 mg) plus Minocycline (100 mg daily)
Number of subjects: 36
Study 2943838 — intervention group
Group type: EXPERIMENTAL
Intervention: EC/IC bypass surgery
Number of subjects: 1377
Study 2943838 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1377
Study 31669564 — intervention group
Group type: EXPERIMENTAL
Intervention: 72 Gy in 36 fractions
Number of subjects: 144
Study 31669564 — intervention group
Group type: COMPARATOR
Intervention: 66 Gy in 33 fractions
Number of subjects: 144
Study 31669564 — intervention group
Group type: EXPERIMENTAL
Intervention: 72 Gy in 36 fractions (higher Gleason score 8-10)
Number of subjects: 144
Study 31669564 — intervention group
Group type: COMPARATOR
Intervention: 66 Gy in 33 fractions (higher Gleason score 8-10)
Number of subjects: 144
Study 29575547 — intervention group
Group type: COMPARATOR
Intervention: Xenograft (deproteinized bovine bone)
Number of subjects: 17
Study 29575547 — intervention group
Group type: EXPERIMENTAL
Intervention: Graftless tenting technique
Number of subjects: 17
Study 27245384 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain intensity
Number of subjects: 0
Study 27245384 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain interference
Number of subjects: 0
Study 24528179 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 year of maintenance with tretinoin, mercaptopurine and methotrexate
Number of subjects: 105
Study 24528179 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 105
Study 22340928 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone ointment
Number of subjects: 240
Study 22340928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 19885779 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld vibration (2.2 mm, 15 Hz, 20 s) using a 2.55 kg Mini‐VibraFlex dumbbell
Number of subjects: 35
Study 19885779 — intervention group
Group type: COMPARATOR
Intervention: Still dumbbell (0 mm, 0 Hz, 20 s)
Number of subjects: 35
Study 17186128 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-session intervention arm
Number of subjects: 0
Study 17186128 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 15365537 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once daily for 5 days
Number of subjects: 349
Study 15365537 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg once daily for 10 days
Number of subjects: 349
Study 15365537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 349